生命科学资讯

ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap

Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis

A dynamic scale-mixture model of motion in natural scenes

Human neurocomputational mechanisms of guilt-driven and shame-driven altruistic behavior

Agilent Technologies Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Biosecure Act appears headed for final passage in defense bill

FDA clears Resmed AI for personalizing CPAP settings

With weight loss windfall, Lilly looks to become ‘backbone’ of global innovation: exec

FDA sets new, higher bar for CAR-T cancer treatments to prove superiority

#ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?

Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment

GSK walks away from remaining Ideaya programs

Mirum gains a hepatitis D drug in $620M buyout of startup Bluejay

FDA misses PDUFA review deadline for Agios' thalassemia drug

Other news to note for Dec. 8, 2025

Regulatory actions for Dec. 8, 2025

Viatris monetizes equity stake in Biocon, gets $400M cash

GSK goes away, Ideaya synthetic lethality bids in-house again

Mirum adds to rare live disease portfolio with $820M Bluejay buy

Dyne says Duchenne drug succeeds in pivotal study, heads to FDA for approval